Gefitinib Onkogen

Gefitinib Onkogen is an oral medication used for targeted therapy in cancer treatment. This pharmaceutical is designed to inhibit specific proteins that contribute to cancer cell growth.

Gefitinib Onkogen is primarily used in the treatment of certain types of cancer. It works by targeting and inhibiting proteins that are involved in the growth and spread of cancer cells. This medication is often prescribed for patients with non-small cell lung cancer that has specific genetic markers. It is important to consult with a healthcare provider to determine if Gefitinib Onkogen is suitable for your condition.

Common effects of Gefitinib Onkogen may include skin rash, diarrhea, and fatigue. Some patients may also experience appetite loss, nausea, and dry skin. These effects can vary in severity and duration. It is advisable to monitor any side effects and report them to a healthcare professional if they become severe or persistent.

Gefitinib Onkogen should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by your healthcare provider. This medication may interact with other drugs, so it is crucial to inform your healthcare provider about all medications you are taking. Pregnant women or those planning to become pregnant should discuss the potential risks with their healthcare provider.

Gefitinib Onkogen may interact with certain medications, including those that are metabolized by the liver. It is important to avoid grapefruit and grapefruit juice, as they can affect the metabolism of this medication. Other drugs that may interact with Gefitinib Onkogen include certain antibiotics, antifungals, and seizure medications. Always consult with a healthcare provider before starting or stopping any medication while taking Gefitinib Onkogen.